Press Releases
Search
-
22 Oct 2020
bioMérieux – Information financière du 3e trimestre 2020
Croissance organique de 19,4 % à taux de change et périmètre constants au terme des 9 premiers mois : 2 266 millions d’euros de chiffre d’affaires +17,5 % de croissance à données publiées Poursuite de...
-
22 Oct 2020
bioMérieux – Third-Quarter 2020 Business Review
Organic growth of 19.4% at constant exchange rates and scope of consolidation over the first nine months of the year: €2,266 million in sales Up 17.5% as reported Further exceptional momentum in the t...
-
08 Oct 2020
AMSP partners with bioMérieux to facilitate supply of high-quality COVID-19 diagnostics
bioMérieux and the Africa Medical Supplies Platform (AMSP), have announced a new partnership to facilitate the supply of high-quality diagnostic solutions from the bioMérieux Pandemic Response Portfol...
-
02 Sep 2020
First-Half 2020 Results
Organic sales growth of 15.7% in first-half 2020: €1,476 million in sales Up 15.8% as reported As expected, a mixed sales performance, with faster momentum in molecular biology solutions contrasting w...
-
16 Jul 2020
Launch of BIOFIRE® MYCOPLASMA test for mycoplasma detection in biopharmaceutical products
bioMérieux, a world leader in the field of in vitro diagnostics, has announced the launch of BIOFIRE® MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biothe...
-
09 Jul 2020
Second-Quarter 2020 Business Performance Preannouncement
In light of the withdrawal of its annual objectives, bioMérieux, a world leader in the field of in vitro diagnostics, today announced preliminary quarterly information about its business activity endi...